Group 1: Laboratory Overview - The laboratory is led by Dr. Rui Bai, a distinguished researcher at Westlake University, focusing on the mechanisms of RNA splicing and its role in gene expression regulation [1] - The lab aims to reveal the functions and mechanisms of RNA in life regulation, emphasizing the importance of precise RNA splicing in maintaining physiological homeostasis [1] - Abnormal splicing can lead to gene expression disorders, potentially causing major diseases such as tumors, immune diseases, and neurological disorders [1] Group 2: Research Directions - Current research focuses on the spatiotemporal regulation of RNA splicing and its impact on cell fate determination [2] - The lab is also investigating novel and non-classical splicing patterns and their underlying mechanisms [2] Group 3: Recruitment Positions - The laboratory is recruiting 4 postdoctoral researchers and assistant researchers with backgrounds in genetics, cell biology, bioinformatics, biochemistry, molecular biology, and structural biology [2][3] - Responsibilities include utilizing CRISPR technology, conducting RNA-seq data analysis, and exploring the biochemical principles of variable splicing regulation [2][3] Group 4: Employment Requirements - Candidates must be under 35 years old, hold or be about to obtain a PhD, and have published research papers as the first author in reputable journals [4] - Strong curiosity for scientific research, independent research capabilities, and good communication skills are essential [4] Group 5: Compensation and Benefits - Competitive salary and research conditions will be provided according to Westlake University's regulations, including social insurance and benefits [7] - Postdoctoral researchers can benefit from various funding policies from Hangzhou city, including housing support and educational services for children [8][9] Group 6: Application Process - Applications are accepted until positions are filled, and interested candidates should submit their materials via email [12] - Required materials include a CV, research statement, and two recommendation letters [13]

Core Viewpoint - Wan Ruixue, a prominent researcher at Westlake University, has made significant breakthroughs in the field of RNA splicing and has received multiple prestigious awards, highlighting the importance of female scientists in advancing scientific research [1][2][5]. Group 1: Achievements and Recognition - Wan Ruixue has received several awards, including the 2018 Young Scientist Award, making her the only Chinese and female recipient among the winners [2][5]. - She has been recognized for her research on the three-dimensional structure of spliceosomes and RNA splicing, which is crucial for understanding gene expression [2][4]. Group 2: Research Focus - The primary focus of Wan Ruixue's research is on RNA splicing, which is a critical step in gene expression that can lead to errors if not properly regulated [4]. - Understanding RNA splicing could lead to new drug targets for cancer treatment, as gene mutations are closely related to cancer development [4][5]. Group 3: Mentorship and Advocacy - Wan Ruixue actively supports young female scientists in her lab, emphasizing the importance of building confidence and providing mentorship [5][6]. - She participates in initiatives to create a more inclusive and supportive environment for women in science, inspired by the successful female scientists she has encountered [5][6].

Core Insights - The research led by Professor Yang Baofeng and his team reveals complex mechanisms of vascular aging and cardiac fibrosis, providing a theoretical foundation for treating challenging cardiovascular diseases [1] Group 1: Vascular Aging - The research focuses on the key RNA regulatory molecule METTL14, which, when specifically reduced in aged mice, significantly improves vascular function and restores elasticity, demonstrating anti-aging effects [2] - Increased expression of METTL14 in endothelial cells during vascular aging modifies specific sites on TLR4 mRNA, leading to chronic low-grade inflammation that accelerates endothelial cell aging and causes vascular stiffness and dysfunction [2] Group 2: Cardiac Fibrosis - The team identified RBMS1, an RNA-binding protein, as a new target for combating cardiac fibrosis, which occurs when elastic heart muscle cells are replaced by stiff fibrous tissue, ultimately leading to heart failure [3] - In patients and mice with heart failure, RBMS1 levels are significantly elevated, and its inhibition or gene knockout effectively slows the progression of heart failure [3] - RBMS1 interferes with the normal function of the LMO7 gene, causing mutations that overactivate the pro-fibrotic factor TGFβ1, leading to cardiac tissue hardening and heart failure [3][4] Group 3: Future Directions - Targeting the inhibition of RBMS1 activity or blocking LMO7 gene mutations presents a promising breakthrough in halting cardiac fibrosis [4] - The research team aims to further explore targeted interventions in RNA regulatory mechanisms, developing comprehensive strategies against fibrosis and vascular aging to address the challenges of an aging population and improve national health [4]